Cryobanks International India

What Cryobanks International India does

Cryobanks International India operates a cryobanking business focused on stem cell and umbilical cord blood storage. The company is headquartered in Gurgaon, India, and was founded in 1993. Firmographic data indicates a headcount of 501-1,000 employees, which is sizable relative to typical single-country cord blood banking peers and suggests either an established regional collection/operation footprint or planned workforce scale. The legal entity operates under the name "Cryobanks India" and is privately held with no exchange listing, ticker, or investor relations page observed.

The company's current public-facing presence is minimal. Its website at cryobanksindia.com displays only a "Launching Soon" placeholder with no products, services, pricing, technology disclosures, certifications, or customer information. No mobile application, API, integrations, social profiles, or detailed contact information are documented in the available sources. Pricing is publicly undisclosed, customer segments are unspecified, and no awards, patents, partnerships, or alliances are recorded. No funding rounds, M&A activity, investor identities, or ownership structure details are evidenced in the input data, and the company is flagged as a private entity with no parent-subsidiary relationships documented.

The leadership data references Ravi Kant Jaipuria with an association to RJ Corp, where he serves as Chairman. This linkage to a diversified Indian conglomerate suggests possible strategic backing or shared ownership dynamics, though no formal ownership structure or control relationship between RJ Corp and Cryobanks International India is disclosed in the available sources. The data does not support further attribution of RJ Corp business lines to Cryobanks' operations.

Name

Cryobanks International India

Legal name

Cryobanks India

Website

https://cryobanksindia.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cryobanks International India is a Gurgaon-based private company in stem cell and umbilical cord blood banking, founded in 1993. The company reports 501-1,000 employees, although its website currently displays only a "Launching Soon" placeholder.

Ownership category

akta.pro rank

Product category

Stem Cell Banking (Family Cord Blood Banking)

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Stem cell banking
• Cord blood banking
• Umbilical cord blood
• Cryopreservation services
• Biorepository services

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Core offering

Cryobanks International India is a stem cell and umbilical cord blood bank that provides collection, processing, and long-term cryogenic storage of biological samples for families in India. The company operates a private family cord blood banking service, collecting cord blood at the time of birth and preserving stem cells for potential future medical use. Detailed pricing, enrollment terms, and storage plans are not disclosed publicly, as the company website is currently a 'Launching Soon' placeholder.

Product overview

Cryobanks International India operates a cryobanking service, but the website displays only a 'Launching Soon' placeholder page with no detailed product, service, or portfolio information available.

Differentiator

Problem solved

Functional benefit

Products and services

• Umbilical Cord Blood Banking Collection, processing, and long-term cryogenic storage of umbilical cord blood stem cells collected at the time of birth, offered to expectant parents and families for potential future medical or therapeutic use.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Emerging players

• StemOne Biologicals: Indian stem cell banking and regenerative medicine company offering cord blood and adult stem cell services. Niche but direct overlap in cryobanking services.
• Regrow Biosciences: Indian cell therapy and stem cell banking company. Overlaps with Cryobanks International India in cellular storage and regenerative medicine applications.
• Novastem Biotherapeutics: Indian regenerative medicine and stem cell storage provider with partial overlap to cord blood banking services. Comparable in cellular preservation technology and customer base.
• ReeLabs: Mumbai-based stem cell banking and processing company serving Indian customers. Comparable in core cryobank offering though smaller scale and more focused on therapeutic stem cell processing.

Direct peers

• LifeCell International: India's largest private cord blood and stem cell bank, offering umbilical cord blood and menstrual blood banking. Directly comparable as a domestic cryobank serving Indian families with the same core service as Cryobanks International India.
• Cord Blood Center (Reliance Life Sciences): Indian cord blood bank operated under Reliance Life Sciences, providing umbilical cord blood and stem cell preservation. Directly comparable service offering and customer segment.
• StemCyte India: Indian arm of US-based StemCyte, offering private and public cord blood banking with hospital partnerships across India. Direct competitor in the same cord blood banking category with similar target customers.
• Cryoviva Biotech: Indian and Southeast Asian cord blood bank offering private umbilical cord blood and stem cell storage with hospital tie-ups. Closely matches Cryobanks International India's service model and target market.

Broad incumbents

• Esperite (Cryo-Save): European-headquartered cord blood and stem cell bank that historically operated in India. Comparable core offering though broader geographic and product footprint.
• Reliance Life Sciences: Diversified Indian life sciences company offering cord blood banking among many other biologics and pharma services. Comparable in cryobank operations but operates across a much broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/cryobanksindia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryobanks International India